You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Clin-Alert

Journal indexing and metrics

Journal Homepage Submission guidelines

Restricted access

Research article

First published online 2019-11

Reporting on Adverse Clinical Events

Volume 57, Issue 21

https://doi.org/10.1177/0069477019888759

Abstract

Keywords

Attention Deficit/Hyperactivity Disorder Medications (295)BCG Vaccine (290)Bevacizumab (300)Cannabidiol (298)Clozapine (291)Cocaine (293)Cytochrome P450 3A Inhibitors (299)Denosumab (297)Dietary Supplement (301)E-Cigarettes (292,303)Gemfibrozil (291)Heroin (293)Loperamide (296)Nutmeg (302)Pevonedistat (299)Ranitidine (294)Vaping (303)

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Reporting on Adverse Clinical Events

Retricted access

Systematic review of national and international guidelines on attention-deficit hyperactivity disorder

Retricted access

Stimulants improve theory of mind in children with attention deficit/hyperactivity disorder

Open access

Post hoc analyses of response rates to pharmacological treatments in children and adolescents with attention-deficit/hyperactivity disorder